DE69533002D1 - Verfahren zur Herstellung von Zwischenprodukten von Inhibitoren Von Enkephalinase und Angiotensin konvertierendem Enzym und Zwischenprodukte davon - Google Patents

Verfahren zur Herstellung von Zwischenprodukten von Inhibitoren Von Enkephalinase und Angiotensin konvertierendem Enzym und Zwischenprodukte davon

Info

Publication number
DE69533002D1
DE69533002D1 DE69533002T DE69533002T DE69533002D1 DE 69533002 D1 DE69533002 D1 DE 69533002D1 DE 69533002 T DE69533002 T DE 69533002T DE 69533002 T DE69533002 T DE 69533002T DE 69533002 D1 DE69533002 D1 DE 69533002D1
Authority
DE
Germany
Prior art keywords
intermediates
enkephalinase
angiotensin
inhibitors
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69533002T
Other languages
English (en)
Other versions
DE69533002T2 (de
Inventor
Gary Alan Flynn
Michael James Genin
Douglas Wade Beight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/535,403 external-priority patent/US5641880A/en
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69533002D1 publication Critical patent/DE69533002D1/de
Application granted granted Critical
Publication of DE69533002T2 publication Critical patent/DE69533002T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69533002T 1994-12-21 1995-11-20 Verfahren zur Herstellung von Zwischenprodukten von Inhibitoren Von Enkephalinase und Angiotensin konvertierendem Enzym und Zwischenprodukte davon Expired - Lifetime DE69533002T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36091594A 1994-12-21 1994-12-21
US360915 1994-12-21
US535403 1995-10-24
US08/535,403 US5641880A (en) 1994-12-21 1995-10-24 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof

Publications (2)

Publication Number Publication Date
DE69533002D1 true DE69533002D1 (de) 2004-06-09
DE69533002T2 DE69533002T2 (de) 2005-05-04

Family

ID=27001069

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69533002T Expired - Lifetime DE69533002T2 (de) 1994-12-21 1995-11-20 Verfahren zur Herstellung von Zwischenprodukten von Inhibitoren Von Enkephalinase und Angiotensin konvertierendem Enzym und Zwischenprodukte davon
DE69515517T Expired - Lifetime DE69515517T2 (de) 1994-12-21 1995-11-20 Verfahren zur herstellung von zwischenprodukten von inhibitoren der enkephalinase und des angiotensin konvertierenden enzyms und zwischenprodukte davon

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69515517T Expired - Lifetime DE69515517T2 (de) 1994-12-21 1995-11-20 Verfahren zur herstellung von zwischenprodukten von inhibitoren der enkephalinase und des angiotensin konvertierenden enzyms und zwischenprodukte davon

Country Status (23)

Country Link
US (1) US5734049A (de)
EP (1) EP0800527B1 (de)
JP (1) JP3658408B2 (de)
CN (2) CN1113894C (de)
AR (1) AR000378A1 (de)
AT (2) ATE190315T1 (de)
AU (1) AU689362B2 (de)
CA (2) CA2208569C (de)
DE (2) DE69533002T2 (de)
DK (2) DK0957109T3 (de)
ES (2) ES2216386T3 (de)
FI (1) FI121599B (de)
GR (1) GR3033329T3 (de)
HK (1) HK1066009A1 (de)
HU (1) HU227675B1 (de)
IL (6) IL139141A (de)
MX (1) MX9704677A (de)
NO (2) NO308900B1 (de)
NZ (2) NZ298245A (de)
PT (2) PT957109E (de)
SI (2) SI0800527T1 (de)
TW (1) TW401413B (de)
WO (1) WO1996019492A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US9695121B2 (en) * 2013-01-30 2017-07-04 Basf Se 2,6-bis-(aminomethyl)piperidine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA874107B (de) * 1986-06-13 1987-12-09
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
NZ241023A (en) * 1990-12-21 1994-10-26 Merrell Dow Pharma Condensed benzazepine derivatives and pharmaceutical compositions
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
ES2106112T3 (es) * 1991-09-27 1997-11-01 Merrell Pharma Inc Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam

Also Published As

Publication number Publication date
DK0800527T3 (da) 2000-06-05
CN1495186A (zh) 2004-05-12
NZ334608A (en) 1999-07-29
IL139141A0 (en) 2001-11-25
US5734049A (en) 1998-03-31
SI0800527T1 (en) 2000-08-31
ES2147863T3 (es) 2000-10-01
HUT78073A (hu) 1999-08-30
JP3658408B2 (ja) 2005-06-08
CA2208569A1 (en) 1996-06-27
CA2297134A1 (en) 1996-06-27
HK1066009A1 (en) 2005-03-11
IL139142A (en) 2004-07-25
DE69515517D1 (de) 2000-04-13
NO972875D0 (no) 1997-06-20
EP0800527A1 (de) 1997-10-15
ES2216386T3 (es) 2004-10-16
FI972620A (fi) 1997-06-18
NO308900B1 (no) 2000-11-13
CA2208569C (en) 2000-07-11
NO972875L (no) 1997-08-20
WO1996019492A1 (en) 1996-06-27
FI121599B (fi) 2011-01-31
ATE190315T1 (de) 2000-03-15
ATE266040T1 (de) 2004-05-15
HU227675B1 (en) 2011-11-28
IL116428A (en) 2001-03-19
GR3033329T3 (en) 2000-09-29
PT800527E (pt) 2000-06-30
DK0957109T3 (da) 2004-06-01
DE69515517T2 (de) 2000-07-06
PT957109E (pt) 2004-09-30
DE69533002T2 (de) 2005-05-04
NO20001822L (no) 1997-08-20
NO20001822D0 (no) 2000-04-07
EP0800527B1 (de) 2000-03-08
CN1241924C (zh) 2006-02-15
CN1170413A (zh) 1998-01-14
IL116428A0 (en) 1996-03-31
NO310025B1 (no) 2001-05-07
JPH10511348A (ja) 1998-11-04
NZ298245A (en) 1999-04-29
AU689362B2 (en) 1998-03-26
IL128996A0 (en) 2000-02-17
MX9704677A (es) 1997-09-30
CN1113894C (zh) 2003-07-09
SI0957109T1 (en) 2004-10-31
AR000378A1 (es) 1997-06-18
IL139142A0 (en) 2001-11-25
AU4368596A (en) 1996-07-10
CA2297134C (en) 2004-02-10
TW401413B (en) 2000-08-11
FI972620A0 (fi) 1997-06-18
IL139141A (en) 2005-11-20

Similar Documents

Publication Publication Date Title
DE69534801D1 (de) Neues lysin decarboxylase gen und verfahren zur herstellung von l-lysin
DE69725169D1 (de) Zusammensetzungen und verfahren zur anregung des wachstums von neuriten
ATE253116T1 (de) Verbesserte antikörper gegen ige und verfahren zur verbesserung von antikörpern
DE69528011D1 (de) Verfahren zur Pflege der Nägel
DE69733137D1 (de) Inhibitoren von picornavirus 3c protease und verfahren zur herstellung und verwendung
DE69727977D1 (de) Verfahren zur simultanen herstellung von acrylnitril und acrylsäure
DE19781891T1 (de) Verbessertes Verfahren zur Umwandlung von Fettsäureamiden IN-Amine
DE69630038D1 (de) Verfahren zur herstellung und aufreinigung von enzymen
DE69732772D1 (de) Enzymatisches verfahren zur stereoselektiven herstellung von therapeutischen amiden
DE69822526D1 (de) Verfahren zur Konservierung von wassergefüllten Materialien
ATE232721T1 (de) Verfahren zur vermehrung der produktion und zur verbesserung der qualität von sperma
DE69430038D1 (de) Verfahren zur Bestimmung der Aktivität des Prophenoloxidaseaktivierenden Enzyms und dessen Anwendung
DE69533002D1 (de) Verfahren zur Herstellung von Zwischenprodukten von Inhibitoren Von Enkephalinase und Angiotensin konvertierendem Enzym und Zwischenprodukte davon
DE69829613D1 (de) Verfahren zur Herstellung von Heteroarylcarbonsäureamiden und -estern
DE69812536T2 (de) Verfahren zur Herstellung von optisch aktiven Aminen und von optischen aktiven Carbonsäuren und Zwischenprodukte dafür
DE69724641D1 (de) Reinigung von fermentierter clavulansäure
DE59905059D1 (de) Verfahren zur Herstellung von Hydroxyethylcyclohexanen und Hydroxyethylpiperidinen
DE69519388T2 (de) Verfahren zur herstellung von 2-(omega-alkoxycarbonylalkanoyl)-4-butanolid und langkettiger omega-hydroxycarbonsäure
DE69633798D1 (de) Immunogenische zusammensetzung und verfahren zur verbesserung der produktivität von wiederkäuern
DE59700696D1 (de) Verfahren und zwischenprodukte zur herstellung von pyridyl-4-fluoranilinen
DE59710990D1 (de) Mittel und Verfahren zur Bestimmung von hydrolytischen Enzymen
DE69805744D1 (de) Verfahren zur Herstellung von alpha-Aminonitrilen und alpha-Aminosäuren
ATA125096A (de) Verfahren zur thermischen behandlung von organisch belasteten materialien
DE69510390D1 (de) Verfahren zur Herstellung von Allylchinon-Derivaten und Zwischenprodukte
ZA9510713B (en) Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS HOLDINGS INC., GREENVILLE, DEL., US

8327 Change in the person/name/address of the patent owner

Owner name: AVENTISUB II INC., GREENVILLE, DEL., US